Sign in
Enrolling by invitationNo phase

Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial

Key facts

Who runs it
National Taiwan University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
90 people, planned
Started
1 Jun 2025
Expected to end
31 Dec 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Enhanced Rehabilitation Program
Record updated
20 July 2026

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Non-traumatic adult patients who experienced sudden cardiac arrest
  • Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation
  • Admitted to the ICU
  • Survived beyond 72 hours without successful weaning from mechanical ventilation

Who cannot take part

  • Terminal-stage cancer or unwillingness to receive aggressive treatment
  • Open wounds, severe edema, or deep vein thrombosis in the lower limbs
  • Age under 18 years
  • Pregnancy
  • Expected to be weaned from mechanical ventilation within 48 hours
  • Unavailability of ICU care due to overcrowding in the emergency intensive care unit
  • Refusal to participate in the study by the patient or family members
  • Presence of an implanted pacemaker or defibrillator
  • Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this research project is to develop an automated muscle mass measurement system based on computed tomography (CT) images using deep learning and artificial intelligence, and to construct a prognostic prediction model for patients who have experienced cardiac arrest and undergone resuscitation. The model will be validated using multicenter registry data and medical imaging. Furthermore, a clinical trial involving core muscle rehabilitation for post-resuscitation patients will be conducted to evaluate both short-term and long-term outcomes, aiming to comprehensively understand the impact of muscle mass on the prognosis of patients after cardiac arrest.

The 2 groups in the trial

  • control groupNo study treatment, for comparison
  • Intervention GroupTreatment being tested

    Participants in the arm group only performed joint-assisted movement.

    Treatment: Enhanced Rehabilitation Program

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comprehensive Interpretation of the Importance of Skeletal Muscle Mass on Prognosis and Recovery in Cardiac Arrest Survivors: From Machine Learning to Clinical Trial
Criteria questions
Built from NCT07034170, who can take part
Record updated
20 July 2026